CORTONE TAB 25MG DIN 00016446
Status: Cancelled Post Market
Holder: MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO.
Molecule: CORTISONE ACETATE
Health Canada record
| Active ingredient(s) | CORTISONE ACETATE 25 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | H02AB10 CORTISONE |
| Original market date | 31-Dec-1954 |
| Current status date | 29-Jul-2002 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CORTISONE ACETATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00280437 | CORTISONE ACETATE | BAUSCH HEALTH, CANADA INC. | Tablet | CORTISONE ACETATE 25 MG | Marketed |
| 00016241 | CORTONE SUS 50MG/ML | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | Suspension | CORTISONE ACETATE 50 MG | Cancelled Post Market |
| 00016438 | CORTONE TAB 5MG | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | Tablet | CORTISONE ACETATE 5 MG | Cancelled Post Market |
International API supply for CORTISONE ACETATE
0 valid EDQM Certificates of Suitability from 0 holders. 13 active FDA Drug Master Files.
Request a quote for CORTONE TAB 25MG